DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy
ST. GALLEN, Switzerland -- (BUSINESS WIRE) -- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial sh......